Cardiac stress test

Cardiac stress test
Intervention

A male patient walks on a stress test treadmill to have his heart's function checked.
ICD-9-CM 89.4
MeSH D025401
MedlinePlus 003878

A cardiac stress test (or cardiac diagnostic test) is a cardiological test that measures a heart's ability to respond to external stress in a controlled clinical environment. The stress response is induced by exercise or by drug stimulation.

Cardiac stress tests compare the coronary circulation while the patient is at rest with the same patient's circulation during maximum physical exertion, showing any abnormal blood flow to the myocardium (heart muscle tissue). The results can be interpreted as a reflection on the general physical condition of the test patient. This test can be used to diagnose coronary artery disease (also known as ischemic heart disease), and for patient prognosis after a myocardial infarction (heart attack).

The cardiac stress test is done with heart stimulation, either by exercise on a treadmill, pedalling a stationary exercise bicycle ergometer,[1] or with intravenous pharmacological stimulation, with the patient connected to an electrocardiogram (ECG). People who cannot use their legs may exercise with a bicycle-like crank that they turn with their arms.[2]

The level of mechanical stress is progressively increased by adjusting the difficulty (steepness of the slope) and speed. The test administrator or attending physician examines the symptoms and blood pressure response. With use of ECG, the test is most commonly called a cardiac stress test, but is known by other names, such as exercise testing, stress testing treadmills, exercise tolerance test, stress test or stress test ECG.

A stress test may also use an echocardiogram (ultrasonic imaging of the heart), or a nuclear stress test (in which a radioisotope dye is injected into the bloodstream).[3]

Stress echocardiography

A stress test may be accompanied by echocardiography.[4] The echocardiography is performed both before and after the exercise so that structural differences can be compared.

A resting echocardiogram is obtained prior to stress. The images obtained are similar to the ones obtained during a full surface echocardiogram, commonly referred to as transthoracic echocardiogram. The patient is subjected to stress in the form of exercise or chemically (usually dobutamine). After the target heart rate is achieved, 'stress' echocardiogram images are obtained. The two echocardiogram images are then compared to assess for any abnormalities in wall motion of the heart. This is used to detect obstructive coronary artery disease.

Nuclear stress test

The best known example of a nuclear stress test is myocardial perfusion imaging. Typically, a radiotracer (Tc-99 sestamibi, Myoview or thallous chloride 201) may be injected during the test. After a suitable waiting period to ensure proper distribution of the radiotracer, scans are acquired with a gamma camera to capture images of the blood flow. Scans acquired before and after exercise are examined to assess the state of the coronary arteries of the patient.

Showing the relative amounts of radioisotope within the heart muscle, the nuclear stress tests more accurately identify regional areas of reduced blood flow.

Stress and potential cardiac damage from exercise during the test is a problem in patients with ECG abnormalities at rest or in patients with severe motor disability. Pharmacological stimulation from vasodilators such as dipyridamole or adenosine, or positive chronotropic agents such as dobutamine can be used. Testing personnel can include a cardiac radiologist, a nuclear medicine physician,a nuclear medicine technologist, a cardiology technologist, a cardiologist, and/or a nurse.

The typical dose of radiation received during this procedure can range from 9.4 millisieverts to 40.7 millisieverts.[5]

Function

Stress-ECG of a patient with coronary heart disease: ST-segment depression (arrow) at 100 watts of exercise. A: at rest, B: at 75 watts, C: at 100 watts, D: at 125 watts.

The American Heart Association recommends ECG treadmill testing as the first choice for patients with medium risk of coronary heart disease according to risk factors of smoking, family history of coronary artery stenosis, hypertension, diabetes and high cholesterol.

Diagnostic value

The common approach for stress testing by American College of Cardiology and American Heart Association indicates the following:[6]

(Sensitivity is the percentage of sick people who are correctly identified as having the condition. Specificity indicates the percentage of healthy people who are correctly identified as not having the condition.) To arrive at the patient's post-test likelihood of disease, interpretation of the stress test result requires integration of the patient's pre-test likelihood with the test's sensitivity and specificity. This approach, first described by Diamond and Forrester in the 1970s,[7] results in an estimate of the patient's post-test likelihood of disease.

The value of stress tests has always been recognized as limited in assessing heart disease such as atherosclerosis, a condition which mainly produces wall thickening and enlargement of the arteries. This is because the stress test compares the patient's coronary flow status before and after exercise and is suitable to detecting specific areas of ischemia and lumen narrowing, not a generalized arterial thickening.

According to American Heart Association data, about 65% of men and 47% of women present with a heart attack or sudden cardiac arrest as their first symptom of cardiovascular disease. Stress tests, carried out shortly before these events, are not relevant to the prediction of infarction in the majority of individuals tested. Over the past two decades, better methods have been developed to identify atherosclerotic disease before it becomes symptomatic. These detection methods include anatomical and physiological methods.

Examples of anatomical methods
Examples of physiological methods

The anatomic methods directly measure some aspects of the actual process of atherosclerosis itself and therefore offer the possibility of early diagnosis, but are often more expensive and may be invasive (in the case of IVUS, for example). The physiological methods are often less expensive and more secure, but are not able to quantify the current status of the disease or directly track progression.

Contraindications and termination conditions

Stress cardiac imaging is not recommended for asymptomatic, low-risk patients as part of their routine care.[8] Some estimates show that such screening accounts for 45% of cardiac stress imaging, and evidence does not show that this results in better outcomes for patients.[8] Unless high-risk markers are present, such as diabetes in patients aged over 40, peripheral arterial disease; or a risk of coronary heart disease greater than 2 percent yearly, most health societies do not recommend the test as a routine procedure.[8][9][10][11]

Absolute contraindications to cardiac stress test include:

A cardiac stress test should be terminated before completion under the following circumstances:[13][14]

Adverse effects

Side effects from cardiac stress testing may include

Pharmacological agents

Pharmacologic stress testing relies on coronary steal. Vasodilators are used to dilate coronary vessels, which causes increased blood velocity and flow rate in normal vessels and less of a response in stenotic vessels. This difference in response leads to a steal of flow, and perfusion defects appear in cardiac nuclear scans or as ST-segment changes. [15]

The choice of pharmacologic stress agents used in the test depends on factors such as potential drug interactions with other treatments and concomitant diseases.

Pharmacologic agents such as Adenosine, Lexiscan (Regadenoson), or dipyridamole is generally used when a patient cannot achieve adequate work level with treadmill exercise, or has poorly controlled hypertension or left bundle branch block. However, an exercise stress test may provide more information about exercise tolerance than a pharmacologic stress test.[16]

Commonly used agents include:

Lexiscan (Regadenoson) or Dobutamine is often used in patients with severe reactive airway disease (Asthma or COPD) as adenosine and dipyridamole can cause acute exacerbation of these conditions. If the patient's Asthma is treated with an inhaler then it should be used as a pre-treatment prior to the injection of the pharmacologic stress agent. In addition, if the patient is actively wheezing then the physician should determine the benefits versus the risk to the patient of performing a stress test especially outside of a hospital setting. Caffeine is usually held 24 hours prior to an adenosine stress test, as it is a competitive antagonist of the A2A adenosine receptor and can attenuate the vasodilatory effects of adenosine.

Aminophylline may be used to attenuate severe and/or persistent adverse reactions to Adenosine and Lexiscan.

Limitations

The stress test does not detect:

The test has relatively high rates of false positives and false negatives compared with other clinical tests.

Results

Once the stress test is completed, the patient generally is advised to not suddenly stop activity, but to slowly decrease the intensity of the exercise over the course of several minutes.

See also

References

  1. "Exercise stress test". MedlinePlus : U.S. National Library of Medicine. Retrieved 31 May 2013.
  2. Terry, Sarah (August 16, 2013). "Treadmill Test for Heart Problems". Livestrong Foundation. Retrieved May 30, 2014.
  3. "Exercise stress test". Texas Heart Institute. July 2015. Retrieved 23 August 2015.
  4. Rimmerman, Curtis (2009-05-05). The Cleveland Clinic Guide to Heart Attacks. Kaplan Publishing. pp. 113–. ISBN 978-1-4277-9968-5. Retrieved 25 September 2011.
  5. Mettler FA, Jr; Huda, W; Yoshizumi, TT; Mahesh, M (July 2008). "Effective doses in radiology and diagnostic nuclear medicine: a catalog.". Radiology 248 (1): 254–63. doi:10.1148/radiol.2481071451. PMID 18566177.
  6. Gibbons, R., Balady, G.; Timothybricker, J., Chaitman, B., Fletcher, G., Froelicher, V., Mark, D., McCallister, B. et al. (2002). "ACC / AHA 2002 guideline update for exercise testing: summary article A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines,Journal of the American College of Cardiology
  7. Diamond GA, Forrester JS. (1979). "Analysis of probability as an aid to the clinical diagnosis of coronary artery disease". New England Journal of Medicine 300: 1350–1358. doi:10.1056/nejm197906143002402.
  8. 1 2 3 American College of Cardiology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation (American College of Cardiology), retrieved August 17, 2012
  9. Taylor, A. J.; Cerqueira, M.; Hodgson, J. M. .; Mark, D.; Min, J.; O'Gara, P.; Rubin, G. D.; American College of Cardiology Foundation Appropriate Use Criteria Task Force; Society of Cardiovascular Computed Tomography; American College Of, R.; American Heart, A.; American Society of Echocardiography; American Society of Nuclear Cardiology; North American Society for Cardiovascular Imaging; Society for Cardiovascular Angiography Interventions; Society for Cardiovascular Magnetic Resonance; Kramer, C. M.; Berman; Brown; Chaudhry, F. A.; Cury, R. C.; Desai, M. Y.; Einstein, A. J.; Gomes, A. S.; Harrington, R.; Hoffmann, U.; Khare, R.; Lesser; McGann; Rosenberg, A. (2010). "ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography". Journal of the American College of Cardiology 56 (22): 1864–1894. doi:10.1016/j.jacc.2010.07.005. PMID 21087721.
  10. Douglas, P. S.; Garcia, M. J.; Haines, D. E.; Lai, W. W.; Manning, W. J.; Patel, A. R.; Picard, M. H.; Polk, D. M.; Ragosta, M.; Ward, R. P.; Douglas, R. B.; Weiner, R. B.; Society for Cardiovascular Angiography Interventions; Society of Critical Care Medicine; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Society for Cardiovascular Magnetic Resonance; Society of Cardiovascular Computed Tomography; American Heart Association; Heart Rhythm Society (2011). "ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography". Journal of the American College of Cardiology 57 (9): 1126–1166. doi:10.1016/j.jacc.2010.11.002. PMID 21349406.
  11. Hendel, R. C.; Abbott, B. G.; Bateman, T. M.; Blankstein, R.; Calnon, D. A.; Leppo, J. A.; Maddahi, J.; Schumaecker, M. M.; Shaw, L. J.; Ward, R. P.; Wolinsky, D. G.; American Society of Nuclear Cardiology (2010). "The role of radionuclide myocardial perfusion imaging for asymptomatic individuals". Journal of Nuclear Cardiology 18 (1): 3–15. doi:10.1007/s12350-010-9320-5. PMID 21181519.
  12. 1 2 3 4 5 Henzlova, Milena; Cerqueira, Hansen; Taillefer, Yao (January 2009). "Stress Protocols and Tracers". Journal of Nuclear Cardiology. doi:10.1007/s12350-009-9062-4.
  13. 1 2 3 Weisman, Idelle M.; Zeballos, R. Jorge, eds. (2002). Clinical exercise testing. Basel: Karger. p. 111. ISBN 9783805572989. Retrieved 26 November 2014.
  14. 1 2 3 4 5 6 7 American College of Sports Medicine (2013). ACSM's Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins. p. 131. ISBN 9781469826660. Retrieved 26 November 2014.
  15. "Pharmacologic Stress Testing". Medscape. Retrieved 3 April, 2016. Check date values in: |access-date= (help)
  16. Weissman, Neil J.; Adelmann, Gabriel A. (2004). Cardiac imaging secrets. Elsevier Health Sciences. pp. 126–. ISBN 978-1-56053-515-7. Retrieved 25 September 2011.
  17. Nicholls, Stephen J.; Worthley, Stephen (January 2011). Cardiovascular Imaging for Clinical Practice. Jones & Bartlett Learning. pp. 198–. ISBN 978-0-7637-5622-2. Retrieved 25 September 2011.

External links

This article is issued from Wikipedia - version of the Sunday, April 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.